![glp-1 receptor agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1 Receptor Agonists and the](https://www.torhoermanlaw.com/wp-content/uploads/2024/09/GLP-1-Vision-Loss-MDL-3163.jpg)
glp-1 receptor agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1 Receptor Agonists and the
Description
Obesity is associated with several cardiometabolic complications, which reduce the quality of life as well as life expectancy
![glp-1 receptor agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1 Receptor Agonists and the](https://media.licdn.com/dms/image/v2/D5622AQGQA8JSZiYbwg/feedshare-shrink_800/B56ZnMayUAJ8Ag-/0/1760071201696?e=2147483647&v=beta&t=b29WOCVfDAwg9luwVcX6PYfzp7rK5hB70hqhI4mrYSw)
It can increase erythropoiesis under certain conditions
![glp-1 receptor agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1 Receptor Agonists and the](https://images.ctfassets.net/4f3rgqwzdznj/2t6DftuWUI0KuIk9hCJl2H/cf33971309e12f70cee6c63ecbd46b99/Diabetic_retinopathy_GoodRx.png)
Also, experiments conducted in primary islet cells have shown that -arrestin1 restricts the insulin secretion response to GLP1R activation, but not to GIPR activation or tirzepatide
![glp-1 receptor agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1 Receptor Agonists and the](https://www.aoa.org/AOA/Images/News_2025/WIF_GLP1_1600x800_v1.png)
GLP-1 has also been found to increase mRNA and protein expression levels of AP2 and PPAR in a dose-dependent manner during pre-3T3-L1 adipocyte differentiation
![glp-1 receptor agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1 Receptor Agonists and the](https://www.gastrojournal.org/cms/asset/2ee98cc6-58e7-4cf1-a0b6-4bad1c97ec39/ga1.jpg)
